Ultrasonics
The question
To ask the Secretary of State for Health and Social Care, what his Department's planned timetable is for the rollout of histotripsy treatment through the NHS.
Answered by Ashley Dalton
Histotripsy is a non-invasive ultrasound treatment that destroys tumours without the need for surgery or radiation. It is delivered through the Edison System, developed by HistoSonics, which is one of eight transformative technologies supported through the Government’s Innovative Devices Access Pathway pilot, which aims to streamline patient access to medical devices that address an unmet clinical need in the National Health Service.
At this stage, the detailed timetable for the potential NHS rollout of histotripsy treatment is still under development. The Department is working with system partners to determine the most appropriate, effective, and equitable approach and aims to communicate this later in the summer. Our aim is to ensure that any rollout is informed by ongoing evidence, supports early adoption in appropriate sites, and aligns with wider NHS priorities.
Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →